Hammes Company welcomes Raymond Scheller as regional vice president
MILWAUKEE, Jan. 16, 2020 /PRNewswire-PRWeb/ -- Hammes Company, the nation's leading healthcare developer as ranked by Modern Healthcare's Construction and Design Survey, is pleased to announce that Raymond Scheller has joined the firm as regional vice president for the Midwest. He will be based out of Hammes Company's headquarters in Milwaukee, Wisconsin.
Scheller, an architect by trade, brings more than 27 years of healthcare facility planning, design and construction experience. Prior to joining Hammes Company, he was the vice president of planning, design and construction for Bon Secours Mercy Health where he provided systemwide leadership across seven states. While at Bon Secours, Scheller was a member of the merger integration team for planning, design and construction and led systemwide infrastructure assessment and capital planning programs. Over his career, he has led the planning and investment of more than $2 billion in healthcare capital projects.
"We are thrilled to welcome Ray to Hammes Company," said Hammes Company President Nancy Connolly. "Having worked on the owner's side for one of the nation's largest health systems, Ray brings a unique and incredibly valuable perspective to our clients and our team."
Scheller is a licensed architect and received a Bachelor of Architecture from the University of Kentucky.
Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 Phase 1/2 clinical trial in Spinal Muscular Atrophy (SMA) Type I at the American...
BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human...
Pleio, Inc. and FountainRx announce their partnership to provide a concierge-level experience to specialty pharmacy patients. The two companies are launching a program to provide patients with human-driven support as they onboard onto their specialty...
JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Moleculin Biotech , a clinical stage pharmaceutical company with a...
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively.
CancerVision and...
